Investment analysts at William Blair reduced their Q1 2025 EPS estimates for shares of Zoetis in a note issued to investors ...
Stock analysts at William Blair cut their Q2 2025 earnings per share estimates for Generac in a research report issued to clients and investors on Thursday, February 13th. William Blair analyst B.
William Blair downgraded Tempus AI Inc (NASDAQ:TEM) to "Market Perform" from "Outperform" given stock's sharp rally rather ...
In a report released today, Sami Corwin from William Blair maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report). The ...
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as the ...
Stephanie Braming, global head of William Blair Investment Management, plans to retire in the fourth quarter, a news release said. She joined the Chicago-based firm in 2004 and served as portfolio ...
William Blair downgraded Sprinklr (CXM) to Market Perform from Outperform without a price target after the company announced a 15% global ...
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts ...
William Blair downgraded Charles River Laboratories to market perform from outperform citing a likely decline in early-stage R&D spending from large pharmaceutical companies. Analysts Max Smock ...
CHICAGO--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results